347 related articles for article (PubMed ID: 28799122)
1. Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
De Paz D; Kao HK; Huang Y; Chang KP
Curr Oncol Rep; 2017 Aug; 19(10):65. PubMed ID: 28799122
[TBL] [Abstract][Full Text] [Related]
2. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the seventh and eighth edition american joint committee on cancer oral cavity staging systems.
Cramer JD; Reddy A; Ferris RL; Duvvuri U; Samant S
Laryngoscope; 2018 Oct; 128(10):2351-2360. PubMed ID: 29658104
[TBL] [Abstract][Full Text] [Related]
4. Risk stratification in oral squamous cell carcinoma using staging of the eighth American Joint Committee on Cancer: Systematic review and meta-analysis.
Almangush A; Pirinen M; Youssef O; Mäkitie AA; Leivo I
Head Neck; 2020 Oct; 42(10):3002-3017. PubMed ID: 32548858
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of non-coding RNA in oral cancer.
Momen-Heravi F; Bala S
Cell Signal; 2018 Jan; 42():134-143. PubMed ID: 29056500
[TBL] [Abstract][Full Text] [Related]
6. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review).
Pekarek L; Garrido-Gil MJ; Sánchez-Cendra A; Cassinello J; Pekarek T; Fraile-Martinez O; García-Montero C; Lopez-Gonzalez L; Rios-Parra A; Álvarez-Mon M; Acero J; Diaz-Pedrero R; Ortega MA
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37859591
[TBL] [Abstract][Full Text] [Related]
7. Novel technologies for oral squamous carcinoma biomarkers in diagnostics and prognostics.
Irimie AI; Braicu C; Cojocneanu-Petric R; Berindan-Neagoe I; Campian RS
Acta Odontol Scand; 2015 Apr; 73(3):161-8. PubMed ID: 25598447
[TBL] [Abstract][Full Text] [Related]
8. The promise of stem cell markers in the diagnosis and therapy of epithelial dysplasia and oral squamous cell carcinoma.
Mohajertehran F; Sahebkar A; Zare R; Mohtasham N
J Cell Physiol; 2018 Nov; 233(11):8499-8507. PubMed ID: 29797575
[TBL] [Abstract][Full Text] [Related]
9. Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers?
Hanemann JA; Oliveira DT; Nonogaki S; Nishimoto IN; de Carli ML; Landman G; Kowalski LP
BMC Cancer; 2014 Jun; 14():395. PubMed ID: 24893577
[TBL] [Abstract][Full Text] [Related]
10. Essentials of oral cancer.
Rivera C
Int J Clin Exp Pathol; 2015; 8(9):11884-94. PubMed ID: 26617944
[TBL] [Abstract][Full Text] [Related]
11. Twenty‑four signature genes predict the prognosis of oral squamous cell carcinoma with high accuracy and repeatability.
Gao J; Tian G; Han X; Zhu Q
Mol Med Rep; 2018 Feb; 17(2):2982-2990. PubMed ID: 29257303
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic signatures of local recurrence in oral squamous cell carcinoma.
Ghantous Y; Bahouth Z; Abu El-Naaj I
Arch Oral Biol; 2018 Nov; 95():141-148. PubMed ID: 30118965
[TBL] [Abstract][Full Text] [Related]
13. Subsite-specific association of DEAD box RNA helicase DDX60 with the development and prognosis of oral squamous cell carcinoma.
Fu TY; Wu CN; Sie HC; Cheng JT; Lin YS; Liou HH; Tseng YK; Shu CW; Tsai KW; Yen LM; Tseng HW; Tseng CJ; Ger LP; Liu PF
Oncotarget; 2016 Dec; 7(51):85097-85108. PubMed ID: 27835882
[TBL] [Abstract][Full Text] [Related]
14. FBXW7 expression affects the response to chemoradiotherapy and overall survival among patients with oral squamous cell carcinoma: A single-center retrospective study.
Arita H; Nagata M; Yoshida R; Matsuoka Y; Hirosue A; Kawahara K; Sakata J; Nakashima H; Kojima T; Toya R; Murakami R; Hiraki A; Shinohara M; Nakayama H
Tumour Biol; 2017 Oct; 39(10):1010428317731771. PubMed ID: 29072128
[TBL] [Abstract][Full Text] [Related]
15. Factors predicting outcome after salvage treatment for stage IV oral squamous cell carcinoma: Evidence of the potential importance of the cyclooxygenase-2-prostaglandin E2 pathway.
Kekatpure VD; Singh M; Selvam S; Shetkar G; Hedne NC; Trivedi NP; Siddappa G; Govindan SV; Suresh A; Rangarajan B; Dannenberg AJ; Kuriakose MA
Head Neck; 2015 Aug; 37(8):1142-9. PubMed ID: 24771596
[TBL] [Abstract][Full Text] [Related]
16. Oral Cancer: Genetics and the Role of Precision Medicine.
Li CC; Shen Z; Bavarian R; Yang F; Bhattacharya A
Dent Clin North Am; 2018 Jan; 62(1):29-46. PubMed ID: 29126492
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
18. AURKA is a predictor of chemotherapy response and prognosis for patients with advanced oral squamous cell carcinoma.
Li Y; Zhang J
Tumour Biol; 2015 May; 36(5):3557-64. PubMed ID: 25547434
[TBL] [Abstract][Full Text] [Related]
19. Increased tumor-infiltrating plasmacytoid dendritic cells predicts poor prognosis in oral squamous cell carcinoma.
Han N; Zhang Z; Liu S; Ow A; Ruan M; Yang W; Zhang C
Arch Oral Biol; 2017 Jun; 78():129-134. PubMed ID: 28242507
[TBL] [Abstract][Full Text] [Related]
20. Salvage treatment for recurrent oral squamous cell carcinoma.
Sun GW; Tang EY; Yang XD; Hu QG
J Craniofac Surg; 2009 Jul; 20(4):1093-6. PubMed ID: 19521259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
